Home › Research › Topics › potent
potent
5 studies tagged potent, dated 1999-07-01 to 2026-07-12. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Anti-amyloid nanobody-Fc fusion protein drives potent amyloid clearance through microglial recruitment 2026-07-12
- Fullerenolates: metallated polyhydroxylated fullerenes with potent anti-amyloid activity 2011-06-28
- Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro 2004-10-01
Studies
5 studies carry this tag.
Date range
1999 to 2026
Top journals
- Alzheimer's & dementia (New York, N. Y.) 1
- Biochemistry 1
- Experimental neurology 1
- Organic & biomolecular chemistry 1
- The Journal of biological chemistry 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Our findings demonstrate that Fc effector function is indispensable for microglial-mediated amyloid clearance in vivo.
-
It has been revealed for the first time that sodium fullerenolate Na(4)[C(60)(OH)(∼30)] (NaFL), a water soluble polyhydroxylated [60]fullerene derivative, destroys amyloid fibrils of the Aβ(1-42) peptide in the brain and prevents their formation in in vitro experiments.
-
Cerebral deposition of amyloid beta-peptide (Abeta) in the brain is an invariant feature of Alzheimer disease (AD).
-
Progressive cerebral amyloid beta-protein (A beta) deposition is believed to play a central role in the pathogenesis of Alzheimer's disease (AD).
-
Widespread cerebral deposition of a 40-43-amino acid peptide called the amyloid beta-protein (Abeta) in the form of amyloid fibrils is one of the most prominent neuropathologic features of Alzheimer's disease.